Literature DB >> 23208065

The role of radiosurgery to the tumor bed after resection of brain metastases.

Jared H Gans1, Daniel M S Raper, Ashish H Shah, Amade Bregy, Deborah Heros, Brian E Lally, Jacques J Morcos, Roberto C Heros, Ricardo J Komotar.   

Abstract

BACKGROUND: Optimal postoperative management paradigm for brain metastases remains controversial.
OBJECTIVE: To conduct a systematic review of the literature to understand the role of postoperative stereotactic radiosurgery after resection of brain metastases.
METHODS: We performed a MEDLINE search of the literature to identify series of patients with brain metastases treated with stereotactic radiosurgery after surgical resection. Outcomes including overall survival, local control, distant intracranial failure, and salvage therapy use were recorded. Patient, tumor, and treatment factors were correlated with outcomes through the use of the Pearson correlation and 2-way Student t test as appropriate.
RESULTS: Fourteen studies involving 629 patients were included. Median survival for all studies was 14 months. Local control was correlated with the median volume treated with radiosurgery (r = -0.766, P < .05) and with the rate of gross total resection (r = .728, P < .03). Mean crude local control was 83%; 1-year local control was 85%. Distant intracranial failure occurred in 49% of cases, and salvage whole-brain radiation therapy was required in 29% of cases. Use of a radiosurgical margin did not lead to increased local control or overall survival.
CONCLUSION: Our systematic review supports the use of radiosurgery as a safe and effective strategy for adjuvant treatment of brain metastases, particularly when gross total resection has been achieved. With all limitations of comparisons between studies, no increase in local recurrence or decrease in overall survival compared with rates with adjuvant whole-brain radiation therapy was found.

Entities:  

Mesh:

Year:  2013        PMID: 23208065     DOI: 10.1227/NEU.0b013e31827fcd60

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  19 in total

1.  Postoperative local fractionated radiotherapy for resected single brain metastases.

Authors:  Ahmad Walid Ayas; Stefan Grau; Karolina Jablonska; Daniel Ruess; Maximilian Ruge; Simone Marnitz; Roland Goldbrunner; Martin Kocher
Journal:  Strahlenther Onkol       Date:  2018-09-14       Impact factor: 3.621

Review 2.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

3.  Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.

Authors:  Mehran B Yusuf; Mark J Amsbaugh; Eric Burton; Megan Nelson; Brian Williams; Maria Koutourousiou; Haring Nauta; Shiao Woo
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

4.  The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.

Authors:  A Gabriella Wernicke; Menachem Z Yondorf; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; John A Boockvar; Susan Pannullo; Philip Stieg; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

5.  Identifying candidates for gamma knife radiosurgery among elderly patients with brain metastases.

Authors:  Tae Hoon Roh; Mi Sun Choi; Namkyu You; Donghwan Jeong; Ae Hwa Jang; Mi Ra Seo; Sang Ryul Lee; Se-Hyuk Kim
Journal:  J Neurooncol       Date:  2018-01-11       Impact factor: 4.130

6.  Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.

Authors:  A Gabriella Wernicke; Menachem Z Yondorf; Luke Peng; Samuel Trichter; Lucy Nedialkova; Albert Sabbas; Fridon Kulidzhanov; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; Paul Christos; Ilhami Kovanlikaya; Susan Pannullo; John A Boockvar; Philip E Stieg; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2014-05-02       Impact factor: 5.115

7.  The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.

Authors:  Michela Buglione; Sara Pedretti; Stefano Gipponi; Luciano Buttolo; Paolo Panciani; Pietro Luigi Poliani; Roberto Liserre; Paolo Borghetti; Ludovica Pegurri; Loredana Costa; Luca Triggiani; Nadia Pasinetti; Paolo Ghirardelli; Sara Pandini; Alessandro Padovani; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2015-04-28       Impact factor: 3.469

Review 8.  Tumor bed radiosurgery: an emerging treatment for brain metastases.

Authors:  Mark J Amsbaugh; Warren Boling; Shiao Woo
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

Review 9.  Treatment of Brain Metastases.

Authors:  Xuling Lin; Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

Review 10.  Postoperative stereotactic radiosurgery for resected brain metastasis.

Authors:  Zain Ahmed; Ehsan Balagamwala; Erin Murphy; Lilyana Angelov; John Suh; Simon Lo; Samuel Chao
Journal:  CNS Oncol       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.